Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 8403845

Comparative study on rat enteromucins.

S Ohara·K Ishihara·K Hotta
View original source ↗Export metadata ↓

Abstract

1. Mucus glycoproteins (mucins) were extracted from the duodenum, small intestine (proximal and distal parts) and colon. 2. Enteromucin subunits were larger than 2 x 10(6). 3. The glycopeptides of enteromucins were essentially the same in size of the subunit. 4. The carbohydrate portion of enteromucins consisted of N-acetylgalactosamine, N-acetylglucosamine, galactose, fucose and sialic acid and the ratios of these sugars differed according to the region. 5. Average oligosaccharide length was about 8, 8, 8 and 14 sugars in the duodenum, proximal small intestine, distal small intestine and colon, respectively. 6. The proportion of threonine to serine in small intestinal mucins differed from duodenal and colonic mucins. Duodenal and colonic mucins were richer in threonine than small intestinal mucins. 7. Proximal and distal small intestinal mucins showed the same features. 8. A comparison of rat enteromucins to gastromucins indicated enteromucins to have large subunits and glycopeptides. The threonine and sialic acid content of enteromucins was higher and fucose content less compared to gastromucins.

Explore related subjects

AcetylgalactosamineAcetylglucosamineAmino AcidsAnimalsCarbohydratesColonDuodenumFucoseGalactoseIntestine, SmallMaleMucinsN-Acetylneuraminic AcidRatsRats, Sprague-DawleySialic AcidsComparative StudyJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S Ohara, K Ishihara, K Hotta. 1993. Comparative study on rat enteromucins.. https://doi.org/10.1016/0305-0491(93)90020-6

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

The location and characterisation of the O-linked glycans of the human insulin receptor.

O-linked glycosylation is a post-translational and post-folding event involving exposed S/T residues at beta-turns or in regions with extended conformation. O-linked sites are difficult to predict from sequence analyses compared to N-linked sites. Here we compare the results of chemical analyses of isolated glycopeptides with the prediction using the neural network prediction method NetOGlyc3.1, a procedure that has been reported to correctly predict 76% of O-glycosylated residues in proteins. Using the heavily glycosylated human insulin receptor as the test protein six sites of mucin-type O-glycosylation were found at residues T744, T749, S757, S758, T759, and T763 compared to the three sites (T759 and T763- correctly, T756- incorrectly) predicted by the neural network method. These six sites occur in a 20 residue segment that begins nine residues downstream from the start of the insulin receptor beta-chain. This region which also includes N-linked glycosylation sites at N742 and N755, is predicted to lack secondary structure and is followed by residues 765-770, the known linear epitope for the monoclonal antibody 18-44.

Acetylgalactosamine↗
PubMed2007

The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.

Initiation of mucin-type O-glycosylation is controlled by a large family of UDP GalNAc:polypeptide N-acetylgalactosaminyltransferases (GalNAc-transferases). Most GalNAc-transferases contain a ricin-like lectin domain in the C-terminal end, which may confer GalNAc-glycopeptide substrate specificity to the enzyme. We have previously shown that the lectin domain of GalNAc-T4 modulates its substrate specificity to enable unique GalNAc-glycopeptide specificities and that this effect is selectively inhibitable by GalNAc; however, direct evidence of carbohydrate binding of GalNAc-transferase lectins has not been previously presented. Here, we report the direct carbohydrate binding of two GalNAc-transferase lectin domains, GalNAc-T4 and GalNAc-T2, representing isoforms reported to have distinct glycopeptide activity (GalNAc-T4) and isoforms without apparent distinct GalNAc-glycopeptide specificity (GalNAc-T2). Both lectins exhibited specificity for binding of free GalNAc. Kinetic and time-course analysis of GalNAc-T2 demonstrated that the lectin domain did not affect transfer to initial glycosylation sites, but selectively modulated velocity of transfer to subsequent sites and affected the number of acceptor sites utilized. The results suggest that GalNAc-transferase lectins serve to modulate the kinetic properties of the enzymes in the late stages of the initiation process of O-glycosylation to accomplish dense or complete O-glycan occupancy.

Acetylgalactosamine↗
PubMed2006

The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.

The epithelial mucin MUC1 is a high molecular weight membrane glycoprotein frequently overexpressed and aberrantly glycosylated in adenocarcinoma. Mucins normally contain high amounts of O-linked carbohydrate structures that may influence immune reactions to this antigen. During malignant transformation, certain glyco-epitopes of MUC1, such as Tn-antigen, TF-antigen and their sialylated forms become exposed. The role of these glycan structures in tumor biology is unknown, but their presence is known to correlate with poor prognosis in several adenocarcinomas. We analyzed the potency of MUC1 containing Tn-antigens (MUC1-Tn) to target C-type lectins that function as carbohydrate recognition and uptake molecules on dendritic cells (DC). We identified the macrophage galactose type C-type lectin (MGL), expressed by both DC and macrophages, as the receptor for recognition and binding of MUC1-Tn. To validate the occurrence of MGL-MUC1 interactions in situ, we studied the binding of MGL to MUC1 in primary colon carcinoma tissue. Isolation of MUC1 out of colon carcinoma tissue showed strong binding activity to MGL. Interestingly, MGL binding to MUC1 was highly correlated to binding by the lectin Helix pomatia agglutinin (HPA), which is associated with poor prognosis in colorectal cancer. The detection of MGL positive cells in situ at the tumor site together with the modified glycosylation status of MUC1 to target MGL on DC suggests that MGL positive antigen presenting cells may play a role in tumor progression.

Acetylgalactosamine↗